Chilam F. Chan
Utrecht, UT 3584CX, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
The Efficacy of Targeted Monoclonal IgA Antibodies Against Pancreatic Ductal Adenocarcinoma.
Journal: Cells
Published: March 20, 2025
Enhancing IgA-mediated neutrophil cytotoxicity against neuroblastoma by CD47 blockade.
Journal: Journal for immunotherapy of cancer
Published: May 06, 2024
Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.0.
Journal: Molecular cancer therapeutics
Published: March 26, 2024
The relevance of tumor target expression levels on IgA-mediated cytotoxicity in cancer immunotherapy.
Journal: Cancer immunology, immunotherapy : CII
Published: March 25, 2024
IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma models.
Journal: Journal for immunotherapy of cancer
Published: June 28, 2023
Effective, Long-Term, Neutrophil Depletion Using a Murinized Anti-Ly-6G 1A8 Antibody.
Journal: Cells
Published: September 29, 2022
Corrigendum: Targeting myeloid checkpoint molecules in combination with antibody therapy: A novel anti-cancer strategy with IgA antibodies?
Journal: Frontiers in immunology
Published: August 12, 2022
Targeting Myeloid Checkpoint Molecules in Combination With Antibody Therapy: A Novel Anti-Cancer Strategy With IgA Antibodies?
Journal: Frontiers in immunology
Published: April 29, 2022
Anti-GD2 IgA kills tumors by neutrophils without antibody-associated pain in the preclinical treatment of high-risk neuroblastoma.
Journal: Journal for immunotherapy of cancer
Published: September 17, 2021
Last Updated: 09/26/2026